Ligand validation:8CV9

HYO: [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate

HYO is a Ligand Of Interest in 8CV9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8CV9_HYO_A_402	71%	56%	0.128	0.948	1.02	0.7	1	1	0	0	100%	1
8CV8_HYO_A_408	86%	55%	0.087	0.957	0.97	0.77	1	1	0	0	100%	1
8CVE_HYO_A_410	79%	49%	0.086	0.932	1.1	0.89	2	1	0	0	100%	1
8CVF_HYO_A_403	38%	52%	0.13	0.829	1.12	0.74	2	1	0	0	100%	0.93
6TTN_HYO_A_506	95%	10%	0.069	0.975	2.91	1.44	13	5	0	0	100%	1
6TTM_HYO_A_402	77%	2%	0.108	0.947	4.96	2.18	14	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.